Vilitra Tablet

What Is Vilitra Tablet?

Vilitra Tablet is a Vardenafil-based oral ED medication manufactured by Centurion Laboratories Pvt. Ltd. Vilitra is the pharmacy-verified generic equivalent of Levitra®, the globally recognized branded Vardenafil medication, available in five strengths to cover the full spectrum of ED severity from mild through severe treatment-resistant cases.

Vardenafil — the active ingredient throughout the Vilitra range — is a second-generation PDE-5 inhibitor developed with specific pharmacological refinements over first-generation Sildenafil. It is approximately 10 times more potent than Sildenafil on a milligram-for-milligram basis, has a higher selectivity for PDE-5 over PDE-6, and produces an onset of 15 to 30 minutes — faster than standard Sildenafil tablets at equivalent as-needed doses.

The Vilitra range covers five strengths: 10mg, 20mg, 40mg, 60mg, and 80mg — from the conservative starting dose through to maximum-range high-strength therapy for severe, treatment-resistant erectile dysfunction.

What Is Vilitra Used For?

• Erectile Dysfunction (ED) in adult men aged 18 years and above — the persistent inability to achieve or maintain an erection sufficient for satisfactory sexual intercourse

Unlike Tadalafil, which has an additional approved indication for benign prostatic hyperplasia (BPH), Vardenafil's approved indication is specifically erectile dysfunction.

Vilitra is particularly well-suited for men who:

• Experienced visual side effects on Sildenafil — blue-tinted vision, light sensitivity, or blurred vision — that have been less prominent with Vardenafil in clinical practice due to higher PDE-6 selectivity
• Need faster onset than standard Sildenafil provides but do not require or want Tadalafil's 36-hour duration
• Have diabetes-associated ED — Vardenafil has consistently demonstrated strong efficacy in diabetic populations across multiple clinical trials
• Have had inconsistent results with Sildenafil and want to trial a pharmacologically different PDE-5 inhibitor before escalating doses
• Prefer a shorter active window than Tadalafil — for men who want the medication's effect to be time-limited rather than persisting through the following day and night

How Does Vardenafil Work?

Vardenafil shares the fundamental PDE-5 inhibition mechanism with all approved ED medications — but its specific pharmacological characteristics distinguish it meaningfully from both Sildenafil and Tadalafil.

Sexual arousal triggers nitric oxide release in penile smooth muscle tissue. Nitric oxide activates guanylate cyclase, which increases cyclic guanosine monophosphate (cGMP) — the chemical messenger responsible for smooth muscle relaxation and vasodilation in erectile tissue. Blood flows into the corpora cavernosa, and an erection forms.

In men with ED, the enzyme PDE-5 degrades cGMP aggressively before an adequate erection can form. Vardenafil selectively inhibits PDE-5 — preserving cGMP and sustaining the vasodilatory response needed for a firm, reliable erection during sexual activity.

General Dosing Information

The Vilitra range covers five distinct strengths — each serving a specific clinical role within the dose escalation pathway:

General dosing guidelines:

• Take one tablet as needed, 15 to 30 minutes before anticipated sexual activity
• Maximum: One tablet per 24-hour period at any dose — never exceed
• New to Vardenafil: Always begin at 10mg — assess response and tolerability before escalation
• Food: Standard meals have minimal impact; avoid very high-fat meals immediately before dosing as these can delay onset
• No daily use formulation exists for Vardenafil — Vilitra is strictly as-needed medication
• Men aged 65+: Start at 5mg (if available) or 10mg — more sensitive to Vardenafil; lower starting dose under medical guidance
• Hepatic impairment: Dose reduction may be required — Vardenafil is primarily liver-metabolized; medical consultation essential
• Renal impairment: Mild-moderate impairment generally does not require adjustment; severe impairment requires medical assessment

Important Safety Precautions

• Are currently using nitrate medications in any form — nitroglycerin, isosorbide mononitrate, isosorbide dinitrate, amyl nitrite (poppers). The combination causes a potentially fatal drop in blood pressure — this is an absolute, non-negotiable contraindication
• Take guanylate cyclase stimulators such as riociguat (Adempas®) — severe hypotension — strictly contraindicated
• Are on antiarrhythmic medications of Class IA or Class III — quinidine, procainamide, amiodarone, sotalol. Vardenafil-specific warning: Vilitra prolongs the QT interval and combining with these drugs creates serious cardiac arrhythmia risk. This contraindication is unique to Vardenafil and does not apply equally to Sildenafil or Tadalafil
• Have congenital QT prolongation syndrome or a family history of QT-related sudden cardiac events
• Have been medically advised to avoid sexual exertion due to cardiovascular disease
• Are allergic to Vardenafil or any tablet excipient
• Are under 18 years of age or a woman

Consult your doctor if you have:

• Heart disease, unstable angina, or a recent heart attack or stroke (within 6 months)
• Uncontrolled high or low blood pressure
• Severe liver disease — Vardenafil is primarily hepatically metabolized; dose adjustment is essential
• Inherited degenerative retinal conditions (retinitis pigmentosa)
• Peyronie's disease or structural penile deformity
• Sickle cell anemia, leukemia, or multiple myeloma
• Prior history of priapism
• Active peptic ulcers or bleeding disorders

Common Adverse Effects

Vilitra Tablet is generally well tolerated — and at standard doses (10mg, 20mg), many men find Vardenafil produces fewer or milder visual side effects than equivalent Sildenafil doses.

Common side effects (up to 1 in 10 users):

• Headache — most frequently reported Vardenafil effect
• Facial flushing or warmth
• Nasal congestion or runny nose
• Indigestion or stomach discomfort
• Dizziness or lightheadedness
• Back pain — less common than with Tadalafil
• Visual disturbances — notably less common than with Sildenafil due to higher PDE-6 selectivity

Less common:
Nausea, dry mouth, palpitations, mild skin redness, temporary blurred vision, fatigue

Side effect frequency and intensity increase with dose. The 10mg and 20mg strengths carry the lowest burden. The 40mg, 60mg, and 80mg strengths carry progressively elevated profiles.

Serious Warning Signs

• Priapism — an erection lasting more than 4 hours — permanent penile tissue damage occurs without immediate treatment
• Sudden loss of vision in one or both eyes — rare NAION (non-arteritic anterior ischemic optic neuropathy)
• Sudden hearing loss or severe acute tinnitus
• Chest pain, irregular heartbeat, or shortness of breath
• Cardiac arrhythmia symptoms — palpitations, dizziness, fainting that may indicate QT prolongation-related rhythm disturbance
• Severe dizziness or fainting
• Anaphylaxis — swelling of face, lips, tongue, or throat; difficulty breathing; widespread hives

The QT prolongation warning is specific to Vardenafil — men taking any cardiac medication should specifically discuss this with their doctor before starting any Vilitra product.

Drug Interactions

Vilitra Tablet shares most PDE-5 inhibitor interactions but carries unique additional interactions — particularly around QT interval prolongation — that do not apply to Sildenafil or Tadalafil products.

Absolutely contraindicated:

• Nitrates — fatal blood pressure collapse
• Riociguat — severe hypotension
• Class IA antiarrhythmics  — Vardenafil-specific QT risk
• Class III antiarrhythmics  — Vardenafil-specific QT risk

Requires medical management:

• Alpha-blockers — additive hypotension, significant fainting risk
• Other PDE-5 inhibitors — combined overdose — never use together
• Strong CYP3A4 inhibitors — dramatically raise Vardenafil plasma levels — dose reduction required
• CYP3A4 inducers  — substantially reduce Vardenafil effectiveness
• Antihypertensives — additive blood pressure lowering
• Thioridazine — additional QT prolongation risk
• Alcohol — reduces erectile function; amplifies dizziness and hypotension
• Grapefruit and grapefruit juice — CYP3A4 inhibition raises Vardenafil concentrations unpredictably

Contraindications

• All men currently taking nitrates in any form or route of administration
• All men taking riociguat or other guanylate cyclase stimulators
• Men with congenital QT prolongation syndrome
• Men on Class IA or III antiarrhythmic medications
• Men with severe hepatic impairment (Child-Pugh Class C)
• Men who have been advised to avoid sexual activity due to cardiovascular risk
• Men with a known hypersensitivity to Vardenafil or any tablet excipient
• Men under 18 years of age
• Women — not indicated

Storage Instructions

• Store at room temperature between 68°F and 77°F (20°C–25°C)
• Keep in original strip packaging until ready for use
• Protect from direct sunlight, heat, and moisture
• Store out of reach of children and pets at all times
• Avoid storing in bathrooms, near sinks, or in high-humidity environments

Frequently Asked Questions

Q: How is Vilitra different from Cenforce and Fildena?
A: Vilitra contains Vardenafil, while Cenforce and Fildena contain Sildenafil. Vardenafil has a faster onset (15–30 min), with a similar 4–5 hour duration.

Q: How is Vilitra different from Vidalista and Tadalista?
A: Vilitra (Vardenafil) lasts 4–5 hours, while Vidalista and Tadalista (Tadalafil) can last up to 36 hours.

Q: Why does Vilitra have a QT prolongation warning?
A: Vardenafil can affect the cardiac QT interval more significantly than Sildenafil or Tadalafil. Men taking QT-affecting antiarrhythmic medicines should disclose their medication history before use.

Q: Which strength should I start with?
A: Vilitra 10mg is the standard recommended starting dose for most adult men. Higher strengths should only be used with medical guidance.

Q: Does food affect Vilitra?
A: Yes, moderately. Very high-fat meals can delay Vardenafil onset. A light or moderate meal may provide more consistent timing.

Q: Is Vilitra effective for men with diabetes?
A: Yes — clinical evidence supports Vardenafil efficacy in men with diabetes-related ED. Consult a healthcare professional about appropriate dosing.